Viemed Healthcare announces 2026 share repurchase program

Viemed Healthcare (VMD) has authorized a share repurchase program effective through March 2027. Under the share repurchase program, which constitutes a normal course issuer bid under applicable Canadian securities laws, Viemed may purchase up to 1,930,131 common shares of the company from time to time, representing approximately 5% of the total issued and outstanding common shares as of March 4. Daily purchases will be limited to 25% of the average daily volume for the four calendar weeks preceding the date of purchase. The company may discontinue its purchases at any time, subject to compliance with applicable securities laws. The common shares purchased by the company will be cancelled.